hEGF plays a variety of biological functions by binding to the specific EGF receptor (EGFR) on the cell surface, and can be used in the treatment of surgical trauma, skin ulcer, peptic ulcer, corneal injury, tissue repair and so on. hEGF can automatically combine with EGFR on the cell membrane near the wound, thereby activating protein kinase, accelerating the synthesis of DNA, RNA and protein, promoting and regulating the growth and value-added of epidermal cells, making the wound heal quickly and repairing skin tissue. The recombinant human epidermal growth factor (rh-EGF) is expressed by extracellular secretion, the amino acid sequence and molecular structure are consistent with the natural hEGF, and has complete biological activity.

Size: 1 mg, 10 mg, 100 mg
Formulation: Lyophilized powder, 5 mM PB(pH 6.8) before lyophilization
Mol. Wt.: 6.2kDa
Theory pI: 4.78
Resources: Escherichia coli (E. coli)
Species：human
Purity: ≥ 95% (SDS-PAGE detection)
Endotoxin: <50 EU/mg
Activity: Activity ≥ 1*106 U/mg(BALB/c 3T3 cell assay)
Storage Condition: -20 ℃
Transport: Ambient Temp
Storage Duration: 3 years